Infections can increase medical costs and worsen patient outcomes. Our aims in pediatric severe traumatic brain injury (sTBI) patients were to determine the infection and fever rates, and to report on associated clinical, imaging, treatment, and outcome factors. We included 180 sTBI patients (presedation Glasgow Coma Scale ≤8 and Maximum Abbreviated Injury Scale ≥4) admitted to our pediatric intensive care unit. Overall, 17% of sTBI patients (n=30 of 180) developed 36 infections, consisting primarily of urinary tract infections (UTIs; n=13 of 36) and ventilator-associated pneumonias (n=11 of 36). Most infections were nosocomial, occurring >2 days after admission. Fever was found in 36% of sTBI patients during the first few hospital days, but fewer than 7% of patients had infections. Infections occurred more frequently in sTBI patients who were older, heavier, and with a higher injury severity score (ISS; p<0.05). Admission head computed tomography imaging abnormalities (subarachnoid hemorrhage, intraventricular hemorrhage, and diffuse axonal injury), placement of an intracranial pressure (ICP) monitor, and administration of ICP-lowering therapies (hypertonic saline, mannitol, and thiopental) were associated with infections (p<0.05). Those with infections had fewer ventilator-free days, greater hospital lengths of stays, and were less likely to be discharged home. Logistic regression demonstrated that infections were independently associated with use of hypertonic saline (odds ratio [OR], 4.46; p=0.001) and higher ISS (OR, 1.05; p=0.028). In summary, infections were prevalent in sTBI patients and were associated with greater head-imaging abnormalities and use of ICP-lowering therapies. Hypertonic saline administration was strongly associated with infection, but further analyses are required to determine the nature of this relationship. Fever was a poor indicator of infection after sTBI.
Get full access to this article
View all access options for this article.
References
1.
GlanceL.G., StoneP.W., MukamelD.B., and DickA.W. (2011). Increases in mortality, length of stay, and cost associated with hospital-acquired infections in trauma patients. Arch. Surg., 146, 794–801.
2.
RaymondJ., and AujardY. (2000). Nosocomial infections in pediatric patients: a European, multicenter prospective study. European Study Group. Infect. Control Hosp. Epidemiol., 21, 260–263.
3.
RichardsM.J., EdwardsJ.R., CulverD.H., and GaynesR.P. (1999). Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics, 103, e39.
4.
GrohskopfL.A., Sinkowitz-CochranR.L., GarrettD.O., SohnA.H., LevineG.L., SiegelJ.D., StoverB.H., and JarvisW.R. (2002). A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States. J. Pediatr., 140, 432–438.
5.
BochicchioG.V., NapolitanoL.M., JoshiM., McCarterR.J.Jr., and ScaleaT.M. (2001). Systemic inflammatory response syndrome score at admission independently predicts infection in blunt trauma patients. J. Trauma, 50, 817–820.
6.
CroceM.A., FabianT.C., Waddle-SmithL., and MaxwellR.A. (2001). Identification of early predictors for post-traumatic pneumonia. Am. Surg., 67, 105–110.
7.
HooverL., BochicchioG.V., NapolitanoL.M., JoshiM., BochicchioK., MeyerW., and ScaleaT.M. (2006). Systemic inflammatory response syndrome and nosocomial infection in trauma. J. Trauma., 61, 310–316; discussion, 316–317.
8.
HellingT.S., EvansL.L., FowlerD.L., HaysL.V., and KennedyF.R. (1988). Infectious complications in patients with severe head injury. J. Trauma, 28, 1575–1577.
9.
BerrouaneY., DaudenthunI., RiegelB., EmeryM.N., MartinG., KrivosicR., and GrandbastienB. (1998). Early onset pneumonia in neurosurgical intensive care unit patients. J. Hosp. Infect., 40, 275–280.
10.
PiekJ., ChesnutR.M., MarshallL.F., van Berkum-ClarkM., KlauberM.R., BluntB.A., EisenbergH.M., JaneJ.A., MarmarouA., and FoulkesM.A. (1992). Extracranial complications of severe head injury. J. Neurosurg., 77, 901–907.
11.
FabregasN., and TorresA. (2002). Pulmonary infection in the brain injured patient. Minerva Anestesiol., 68, 285–290.
12.
KimuraF., ShimizuH., YoshidomeH., OhtsukaM., and MiyazakiM. (2010). Immunosuppression following surgical and traumatic injury. Surg. Today, 40, 793–808.
13.
PascualJ.L., KhwajaK.A., FerriL.E., GianniasB., EvansD.C., RazekT., MichelR.P., and ChristouN.V. (2003). Hypertonic saline resuscitation attenuates neutrophil lung sequestration and transmigration by diminishing leukocyte-endothelial interactions in a two-hit model of hemorrhagic shock and infection. J. Trauma, 54, 121–130; discussion, 130–122.
14.
KhanR., KirschenbaumL.A., LarowC., and AstizM.E. (2011). The effect of resuscitation fluids on neutrophil-endothelial cell interactions in septic shock. Shock, 36, 440–444.
15.
PetersonK., CarsonS., and CarneyN. (2008). Hypothermia treatment for traumatic brain injury: a systematic review and meta-analysis. J. Neurotrauma, 25, 62–71.
16.
NadalP., NicolasJ.M., FontC., VilellaA., and NogueS. (1995). Pneumonia in ventilated head trauma patients: the role of thiopental therapy. Eur. J. Emerg. Med., 2, 14–16.
17.
BoddieD.E., CurrieD.G., EreminO., and HeysS.D. (2003). Immune suppression and isolated severe head injury: a significant clinical problem. Br. J. Neurosurg., 17, 405–417.
18.
DziedzicT., SlowikA., and SzczudlikA. (2004). Nosocomial infections and immunity: lesson from brain-injured patients. Crit. Care, 8, 266–270.
19.
AlharfiI.M., StewartT.C., FosterJ., MorrisonG.C., and FraserD.D. (2013). Central diabetes insipidus in pediatric severe traumatic brain injury. Pediatr. Crit. Care Med., 14, 203–209.
20.
AlharfiI.M., StewartT.C., KellyS.H., MorrisonG.C., and FraserD.D. (2013). Hypernatremia is associated with increased risk of mortality in pediatric severe traumatic brain injury. J. Neurotrauma, 30, 361–366.
21.
StewartT.C., AlharfiI.M., and FraserD.D. (2013). The role of serious concomitant injuries in the treatment and outcome of pediatric severe traumatic brain injury. J. Trauma Acute Care Surg., 75, 836–842.
22.
NgoQ.N., RangerA., SinghR.N., KorneckiA., SeabrookJ.A., and FraserD.D. (2009). External ventricular drains in pediatric patients. Pediatr. Crit. Care Med., 10, 346–351.
23.
HutchisonJ., WardR., LacroixJ., HebertP., SkippenP., BarnesM., MeyerP., MorrisK., KirpalaniH., SinghR., DirksP., BohnD., and MoherD. (2006). Hypothermia pediatric head injury trial: the value of a pretrial clinical evaluation phase. Dev. Neurosci., 28, 291–301.
24.
El-RadhiA.S., and BarryW. (2006). Thermometry in paediatric practice. Arch. Dis. Child., 91, 351–356.
25.
Centers for Disease Control and Prevention. (2010). Healthcare-associated infections (HAIs): ventilator-associated pneumonia (VAP). Centers for Disease Control and Prevention: Atlanta, GA. Available at: www.cdc.gov/hai/vap/vap.html. Accessed December3, 2013.
26.
Centers for Disease Control and Prevention. (2010). Healthcare-associated infections (HAIs): catheter-associated urinary tract infections (CAUTI). Centers for Disease Control and Prevention: Atlanta, GA. Available at: www.cdc.gov/HAI/ca_uti/uti.html. Accessed December3, 2013.
27.
Centers for Disease Control and Prevention. (2010). Healthcare-associated infections (HAIs): Central Line-associated Bloodstream Infection (CLABSI). Centers for Disease Control and Prevention: Atlanta, GA. Available at: www.cdc.gov/hai/bsi/bsi.html. Accessed December3, 2013.
28.
HosmerD., and LemeshowS. (1989). Applied Logistic Regression. Wiley: New York.
29.
HutchisonJ.S., WardR.E., LacroixJ., HebertP.C., BarnesM.A., BohnD.J., DirksP.B., DoucetteS., FergussonD., GottesmanR., JoffeA.R., KirpalaniH.M., MeyerP.G., MorrisK.P., MoherD., SinghR.N., and SkippenP.W. (2008). Hypothermia therapy after traumatic brain injury in children. N. Engl. J. Med., 358, 2447–2456.
30.
NataleJ.E., JosephJ.G., HelfaerM.A., and ShaffnerD.H. (2000). Early hyperthermia after traumatic brain injury in children: risk factors, influence on length of stay, and effect on short-term neurologic status. Crit. Care Med., 28, 2608–2615.
31.
SuzP., VavilalaM.S., SouterM., MuangmanS., and LamA.M. (2006). Clinical features of fever associated with poor outcome in severe pediatric traumatic brain injury. J. Neurosurg. Anesthesiol., 18, 5–10.
32.
BoneR.C. (1996). Sir Isaac Newton, sepsis, SIRS, and CARS. Crit. Care Med., 24, 1125–1128.
33.
PatelJ.C., MollittD.L., and TepasJ.J.3rd., (2000). Infectious complications in critically injured children. J. Pediatr. Surg., 35, 1174–1178.
34.
UrreaM., TornerF., PonsM., LatorreC., and HuguetR. (2005). Incidence study of nosocomial infection in pediatric trauma patients. J. Pediatr. Orthop. B., 14, 371–374.
35.
BrookI. (1998). Aerobic and anaerobic microbiology of infections after trauma in children. J. Accid. Emerg. Med., 15, 162–167.
36.
TairaB.R., FentonK.E., LeeT.K., MengH., McCormackJ.E., HuangE., SingerA.J., ScrivenR.J., and ShapiroM.J. (2009). Ventilator-associated pneumonia in pediatric trauma patients. Pediatr. Crit. Care Med., 10, 491–494.
37.
National Nosocomial Infections Surveillance System. (2004). National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control, 32, 470–485.
38.
CieslaD.J., MooreE.E., GonzalezR.J., BifflW.L., and SillimanC.C. (2000). Hypertonic saline inhibits neutrophil (PMN) priming via attenuation of p38 MAPK signaling. Shock, 14, 265–269; discussion, 269–270.
39.
JungerW.G., RhindS.G., RizoliS.B., CuschieriJ., ShiuM.Y., BakerA.J., LiL., ShekP.N., HoytD.B., and BulgerE.M. (2012). Resuscitation of traumatic hemorrhagic shock patients with hypertonic saline-without dextran-inhibits neutrophil and endothelial cell activation. Shock, 38, 341–350.
40.
PascualJ.L., FerriL.E., SeelyA.J., CampisiG., ChaudhuryP., GianniasB., EvansD.C., RazekT., MichelR.P., and ChristouN.V. (2002). Hypertonic saline resuscitation of hemorrhagic shock diminishes neutrophil rolling and adherence to endothelium and reduces in vivo vascular leakage. Ann. Surg., 236, 634–642.
41.
CieslaD.J., MooreE.E., BifflW.L., GonzalezR.J., and SillimanC.C. (2001). Hypertonic saline attenuation of the neutrophil cytotoxic response is reversed upon restoration of normotonicity and reestablished by repeated hypertonic challenge. Surgery, 129, 567–575.
42.
KimJ.Y., HongY.S., ChoiS.H., YoonY.H., MoonS.W., and LeeS.W. (2012). Effect of hypertonic saline on apoptosis of polymorphonuclear cells. J. Surg. Res., 178, 401–408.
43.
KochanekP.M., CarneyN., AdelsonP.D., AshwalS., BellM.J., BrattonS., CarsonS., ChesnutR.M., GhajarJ., GoldsteinB., GrantG.A., KissoonN., PetersonK., SeldenN.R., TaskerR.C., TongK.A., VavilalaM.S., WainwrightM.S., and WardenC.R. (2012). Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents—second edition. Pediatr. Crit. Care Med., 13, Suppl 1, S1–S82.
44.
FinkM.E. (2012). Osmotherapy for intracranial hypertension: mannitol versus hypertonic saline. Continuum, 18, 640–654.
45.
Correa-SalesC., TostaC.E., and RizzoL.V. (1997). The effects of anesthesia with thiopental on T lymphocyte responses to antigen and mitogens in vivo and in vitro. Int. J. Immunopharmacol., 19, 117–128.
46.
PloppaA., KieferR.T., NoheB., HaeberleH.A., DieterichH.J., UnertlK.E., DurieuxM.E., and KruegerW.A. (2008). Monocyte phagocytosis of viable Staphylococcus aureus is impaired by barbiturates, but not by propofol. Infection, 36, 220–225.
47.
GalleyH.F., DiMatteoM.A., and WebsterN.R. (2000). Immunomodulation by anaesthetic, sedative and analgesic agents: does it matter?. Intensive Care Med., 26, 267–274.
48.
SchneemilchC.E., HachenbergT., AnsorgeS., IttensonA., and BankU. (2005). Effects of different anaesthetic agents on immune cell function in vitro. Eur. J. Anaesthesiol., 22, 616–623.
49.
AllisonK.R., BrynildsenM.P., and CollinsJ.J. (2011). Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature, 473, 216–220.
